Continuous Ambulatory Peritoneal Dialysis (CAPD) Market
Report ID: SQMIG35A3291
Report ID: SQMIG35A3291
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3291 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
143
|Figures:
78
Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market size was valued at USD 9.5 Billion in 2024 and is poised to grow from USD 10.05 Billion in 2025 to USD 15.78 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).
Rising prevalence of chronic kidney disease, growing preference for home-based dialysis therapies, increasing aging population, advancements in dialysate formulations and catheter technologies, and emphasis on cost-effective renal care are driving the demand for continuous ambulatory peritoneal dialysis (CAPD).
Countries such as China and India have adopted community-based CAPD initiatives to improve treatment access, while developed markets focus on reimbursement support and quality care benchmarks. Additionally, the convergence of healthcare cost containment pressures and technological advancements such as telehealth monitoring, improved dialysate formulations, and advanced catheter materials is expected to further strengthen CAPD adoption by reducing complications and hospitalizations. The rapid increase in aging population and the rising burden of end-stage renal disease are also promoting the adoption of CAPD solutions. Growing incidence of chronic kidney disease around the world coupled with increasing patient preference for home-based renal replacement therapies are expected to primarily drive continuous ambulatory peritoneal dialysis (CAPD) market growth.
On the contrary, risk of peritonitis and catheter-related infections, lack of trained professionals and patient awareness in developing regions, high costs associated with dialysis supplies, and clinical complications related to long-term CAPD use are anticipated to slow down continuous ambulatory peritoneal dialysis (CAPD) market penetration going forward.
How is AI Improving Patient Adherence and Outcomes in the Continuous Ambulatory Peritoneal Dialysis Market?
AI is improving patient adherence and treatment outcomes by enabling remote patient monitoring, predictive analytics, and personalized support for continuous ambulatory peritoneal dialysis (CAPD) companies. AI models can detect adherence risks and potential infections early, enabling timely outreach and targeted patient education. Digital coaching tools and automated alerts also help patients follow their prescribed treatment routines and manage issues at home. These technologies reduce response times, lower avoidable hospital visits, and make home-based dialysis care more reliable and proactive.
Market snapshot - 2026-2033
Global Market Size
USD 9.5 Billion
Largest Segment
Capd Solutions
Fastest Growth
Capd Equipment & Accessories
Growth Rate
5.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global continuous ambulatory peritoneal dialysis (CAPD) market is segmented by product type, dialysis modality, patient type, end users, distribution channel, and region. Based on product type, the market is segmented into CAPD solutions and CAPD equipment & accessories. Based on dialysis modality, the market is segmented into traditional CAPD and automated CAPD (APD). Based on patient type, the market is segmented into adult patients, pediatric patients, and geriatric patients. Based on end users, the market is segmented into hospitals, dialysis centers (independent), home healthcare settings, specialty clinics, and others. Based on distribution channel, the market is segmented into online and offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The CAPD solutions segment is estimated to account for the highest global continuous ambulatory peritoneal dialysis (CAPD) market share in the future. The basic importance of these consumable fluid formulations, the constant clinical input that facilitates CAPD therapy delivery and continuity, is what is allowing this segment to gain ascendancy over other segments. This ascendancy is a result of constant refinement of the formulations for biocompatibility, stability, and infection control, as well as clinician preference and recognition of the consumability of the products. The depth of the supply chain and the level of differentiation of the products are what is making hospitals and home providers favor established solution portfolios.
However, CAPD equipment & accessories are emerging as the most rapidly expanding segment as per this continuous ambulatory peritoneal dialysis (CAPD) industry analysis. Innovation in cyclers, tubing, connectors, and disposables that improve safety, usability, and home compatibility is an opportunity for the players in the market. Innovation in the ergonomics of the devices, connectivity for remote monitoring, and partnerships between the manufacturers and the providers of home care services is improving the adoption of the products.
The automated CAPD (APD) segment is expected to spearhead the global continuous ambulatory peritoneal dialysis (CAPD) market revenue generation in the long run. The capacity of automation technology in the delivery of nocturnal, programmatic therapy that fits in with patient lifestyles, as well as clinical goals, further helps solidify the position of this particular segment. Improvements in technology with regard to cycler accuracy, as well as integration with remote monitoring, help increase interest from clinicians and payers, while the simplicity of burden reduction, as well as scalability in the home setting, helps providers prioritize APD capable services.
Nevertheless, traditional CAPD is also emerging as the most rapidly expanding segment because of the low technology requirements and the minimum equipment needs associated with this form of CAPD. Simplification of exchange protocols, patient education programs, and peritonitis prevention practices are also increasing patient confidence and are helping the expansion of CAPD therapy at the community level.
To get detailed segments analysis, Request a Free Sample Report
Robust clinical endorsement of home-based renal replacement modalities, well developed outpatient care infrastructure, and comprehensive patient support services allow North America to lead global CAPD demand. Payers who understand the value of a patient-centered approach to healthcare have provided opportunities for more expansive provider adoption. Similarly, established supply chains and the presence of experienced dialysis providers help to ensure training and the continuity of care after initiation of therapy. There are many ways that technology, including remote monitoring and simplified exchange systems, improve safety and convenience for clinicians to recommend to patients. Active professional societies and continuing education programs provide practical skills to providers and caregivers.
Well-developed outpatient infrastructure and established payer mechanisms that support home based dialysis support steady demand for continuous ambulatory peritoneal dialysis (CAPD) in the United States. Strong training initiatives, infection prevention strategies, and patient education programs have been promoted by clinical leaders, while strong distribution networks and vendor support have facilitated device innovation, remote monitoring, and infection prevention strategies to help clinicians manage patients effectively in non-hospital settings. Patient preferences have ensured continuous consideration of CAPD as one of the modalities of renal treatments.
Integrated provincial care models and emphasis on community-based care are expected to shape the demand for CAPD solutions in Canada. Renal clinics, together with primary care services, help to identify patients, while community-based initiatives focus on training, ensuring continuous supplies, and providing caregiver support, thus making CAPD a viable option. Technology-enabled remote monitoring, together with targeted education, helps manage infection risk and technique issues.
Broad clinical adoption, supportive healthcare policy emphasis, and strong manufacturing presence across key markets are helping Asia Pacific emerge as a highly opportune region for CAPD companies. Local manufacturers and innovative suppliers have made significant investments in supply chain resiliency along with providing tailored products to increase access to their products for chronic kidney patients within the Asia Pacific region. The development of education programs and collaboration between different providers and Industry will drive technical training and increased patient support for the continued success of this mode of treatment as a major component of renal care. Ongoing demographic changes and increasing clinician/patient awareness of renal disease will further support the growing market for CAPD.
Established clinical pathways, robust hospital networks, and presence of a massive geriatric population makes Japan an opportune market for CAPD providers. Local industry support provides reliable products and training programs. Patient programs focus on technique retention and infection control. Joint research and demonstration efforts help fine-tune the practice and device selection. This increases the confidence of healthcare providers and patients alike in the use of CAPD as a home-based therapy.
Increasing clinician familiarity with home dialysis frameworks, supported by integrated hospital services and active nephrology societies drives continuous ambulatory peritoneal dialysis (CAPD) adoption in South Korea. Domestic device manufacturers collaborate with international suppliers in making the product suitable for the region, and training programs concentrate on the skills of the patient and the caregiver. Patient education programs and care pathways promote compliance and minimize the risk of complications, making CAPD an acceptable option in the realm of RRT.
Coordinated clinical guidance, active professional networks, and strategic collaborations between manufacturers and healthcare providers form the base for continuous ambulatory peritoneal dialysis (CAPD) providers to succeed in Europe. Emphasis on integrated care pathways and patient-centric chronic disease management from a regional perspective is encouraging the use of home therapies, while a solid foundation of clinical research and guidance is informing best practice. Sharing clinical expertise and specific training programs also builds proficiency in techniques among clinicians and caregivers. Development of infection control measures, device technology, and online support is also aiding the modality, building clinician confidence and encouraging patients to consider CAPD as an option in national approaches to renal care. Reimbursable and specific grant allocation for pilot programs, as well as patient organization, are also helping to roll out the modality and share knowledge across health systems.
Hospital-led nephrology networks and focused outpatient services that support home dialysis adoption are governing continuous ambulatory peritoneal dialysis (CAPD) demand in Germany. Clinical societies offer guidance and education, while manufacturers help to make products available along with technical support. Focusing on infection control, patient education, and multidisciplinary care pathways can help clinicians manage CAPD effectively. Interworking between research centers and renal hubs can also help to fine-tune the protocol and enhance practitioner skills in home-based dialysis delivery.
Adoption of integrated care models and clinical guidance that support home dialysis pathways shapes the adoption of continuous ambulatory peritoneal dialysis (CAPD) solutions in the country. Partnerships with academic institutions and industry help with device adaptation and remote monitoring solutions for the outpatient setting. This increases the confidence of the healthcare providers and provides more avenues for patients who require renal replacement therapy across the United Kingdom.
Expansion of coordinated outpatient services and emphasis on home based renal care are boosting the demand for Continuous ambulatory peritoneal dialysis (CAPD) across France. Renal manufacturers offer device options and support. The regional networks have been testing the implementation of CAPD and improving infection control measures. This increases the overall focus and patient engagement in CAPD and encourages the integration of CAPD into the national health care system.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Chronic Kidney Disease Prevalence
Technological Improvements in PD Supplies
Limited Reimbursement Coverage
Infection Risk and Clinical Concerns
Request Free Customization of this report to help us to meet your business objectives.
Competitive pressure in the global CAPD market is intensifying as incumbent suppliers and new entrants compete on home first technologies, infection mitigation and connectivity. Strategic M&A and licensing have accelerated capability builds, for example Baxter’s Hillrom purchase and Fresenius’s acquisition of NxStage. Startups are driving sensor and portable cycler innovation, as seen with CloudCath’s FDA cleared monitoring system and Byonyks’ recent APD approvals.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, rising prevalence of chronic kidney disease and growing preference for home-based renal replacement therapies are anticipated to drive the demand for continuous ambulatory peritoneal dialysis (CAPD) going forward. However, risk of peritonitis and catheter-related infections along with lack of trained professionals in developing regions are slated to slow down the adoption of continuous ambulatory peritoneal dialysis (CAPD) in the future. North America is slated to spearhead the demand for continuous ambulatory peritoneal dialysis (CAPD) owing to strong reimbursement support and the presence of a well-established dialysis care infrastructure. Advancements in telehealth monitoring, improved dialysate formulations, and development of more efficient catheter technologies are anticipated to be key trends driving the continuous ambulatory peritoneal dialysis (CAPD) sector over the coming years.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 9.5 Billion |
| Market size value in 2033 | USD 15.78 Billion |
| Growth Rate | 5.8% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Continuous Ambulatory Peritoneal Dialysis (CAPD) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Continuous Ambulatory Peritoneal Dialysis (CAPD) Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Continuous Ambulatory Peritoneal Dialysis (CAPD) Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Continuous Ambulatory Peritoneal Dialysis (CAPD) Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market size was valued at USD 9.5 Billion in 2024 and is poised to grow from USD 10.05 Billion in 2025 to USD 15.78 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).
Competitive pressure in the global CAPD market is intensifying as incumbent suppliers and new entrants compete on home first technologies, infection mitigation and connectivity. Strategic M&A and licensing have accelerated capability builds, for example Baxter’s Hillrom purchase and Fresenius’s acquisition of NxStage. Startups are driving sensor and portable cycler innovation, as seen with CloudCath’s FDA cleared monitoring system and Byonyks’ recent APD approvals. 'Baxter International Inc.', 'Fresenius Medical Care AG & Co. KGaA', 'Medtronic plc', 'B. Braun Melsungen AG', 'CareDX, Inc.', 'Terumo Corporation', '3M Health Care', 'Dialysis Clinic, Inc.', 'Gambro AB', 'Nipro Corporation', 'ICU Medical, Inc.', 'Sorin Group', 'NxStage Medical, Inc.', 'Asahi Kasei Medical Co., Ltd.', 'DaVita Inc.', 'Abbot Laboratories', 'Polymedicure Inc.', 'Medline Industries, Inc.', 'Renal Services Group', 'Fresenius Kabi AG'
Rising prevalence of chronic kidney disease increases the pool of patients requiring dialysis and thereby elevates demand for user-friendly, home-based therapies such as continuous ambulatory peritoneal dialysis. As healthcare systems emphasize outpatient care, clinicians and patients prefer modalities that support autonomy and reduce facility dependency. This trend encourages investment in training, supplies, and support services that make CAPD more accessible and acceptable, reinforcing market expansion through broader adoption by both patients seeking convenience and providers prioritizing capacity management and enhancing care continuity.
Expansion Of Home Based Care: Providers and patients increasingly prefer peritoneal dialysis modalities enabling treatment outside acute settings, driving investment in patient education, nursing support programs, and simplified device designs. Payers and health systems emphasize continuity of care, reduced hospital dependency, and patient quality of life, prompting collaborations to scale training and supply logistics. Manufacturers focus on usability, portability, and consumable convenience to support adoption. The trend fosters decentralized delivery models, strengthens caregiver involvement, and encourages integrated care pathways aligning clinical outcomes with patient-centered design.
Robust clinical endorsement of home-based renal replacement modalities, well developed outpatient care infrastructure, and comprehensive patient support services allow North America to lead global CAPD demand.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
